Verastem to Present at Jefferies 2015 Healthcare Conference

BOSTON--(BUSINESS WIRE)-- Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will present at the Jefferies 2015 Healthcare Conference on Wednesday, June 3 at 10:30 a.m. ET at the Grand Hyatt New York in New York City.

A live webcast of the presentation will be available on the company's website at http://phx.corporate-ir.net/phoenix.zhtml?c=250749&p=irol-calendar. An archived presentation will be available for 90 days.

About Verastem, Inc.

Verastem, Inc. (NASDAQ: VSTM) is discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK and PI3K/mTOR. For more information, please visit www.verastem.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150527005262/en/

Verastem, Inc.
Brian Sullivan, 781-292-4214
[email protected]

Source: Verastem, Inc.

You May Also Be Interested In

• Crypto Price Prediction: Bitcoin’s Market Share Takes Focus as Remittix’s $33M Raise Meets a 300M RTX Burn Plan
• Crypto News: Oil Ends the Week Near $117 as Bitcoin Holds Around $80K and Remittix Plans a 300M RTX Burn
• Positive Overall Survival Results from the Phase III HARMONi-GI1 Trial of Ivonescimab Plus Chemotherapy Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer Presented at the ESMO 202